keyword
https://read.qxmd.com/read/38635839/comorbidities-affecting-re-admission-and-survival-in-covid-19-application-of-joint-frailty-model
#1
JOURNAL ARTICLE
Akram Yazdani, Seyyed Ali Mozaffarpur, Pouyan Ebrahimi, Hoda Shirafkan, Hamed Mehdinejad
BACKGROUND: One of the common concerns of healthcare systems is the potential for re-admission of COVID-19 patients. In addition to adding costs to the healthcare system, re-admissions also endanger patient safety. Recognizing the factors that influence re-admission, can help provide appropriate and optimal health care. The aim of this study was to assess comorbidities that affect re-admission and survival in COVID-19 patients using a joint frailty model. METHODS: This historical cohort study was done using data of patients with COVID-19 who were re-hospitalized more than twice in a referral hospital in North of Iran...
2024: PloS One
https://read.qxmd.com/read/38627848/pheseq-a-bayesian-deep-learning-model-to-enhance-and-interpret-the-gene-disease-association-studies
#2
JOURNAL ARTICLE
Xinzhi Yao, Sizhuo Ouyang, Yulong Lian, Qianqian Peng, Xionghui Zhou, Feier Huang, Xuehai Hu, Feng Shi, Jingbo Xia
Despite the abundance of genotype-phenotype association studies, the resulting association outcomes often lack robustness and interpretations. To address these challenges, we introduce PheSeq, a Bayesian deep learning model that enhances and interprets association studies through the integration and perception of phenotype descriptions. By implementing the PheSeq model in three case studies on Alzheimer's disease, breast cancer, and lung cancer, we identify 1024 priority genes for Alzheimer's disease and 818 and 566 genes for breast cancer and lung cancer, respectively...
April 16, 2024: Genome Medicine
https://read.qxmd.com/read/38625861/immunotherapy-utilization-patterns-in-patients-with-advanced-cancer-and-autoimmune-disease
#3
JOURNAL ARTICLE
Huaqi Li, Scott Huntington, Cary Gross, Shi-Yi Wang
PURPOSE: Immunotherapy has been shown to improve cancer survival, but there are no consensus guidelines to inform use in patients with both cancer and autoimmune disease (AD). We sought to examine immunotherapy utilization patterns between cancer patients with and without AD. PATIENTS AND METHODS: This retrospective cohort study utilized data from a de-identified nationwide oncology database. Patients diagnosed with advanced melanoma, non-small cell lung cancer, and renal cell carcinoma were included...
2024: PloS One
https://read.qxmd.com/read/38621836/advanced-hybrid-attention-based-deep-learning-network-with-heuristic-algorithm-for-adaptive-ct-and-pet-image-fusion-in-lung-cancer-detection
#4
JOURNAL ARTICLE
P Shyamala Bharathi, C Shalini
Lung cancer is one of the most deadly diseases in the world. Lung cancer detection can save the patient's life. Despite being the best imaging tool in the medical sector, clinicians find it challenging to interpret and detect cancer from Computed Tomography (CT) scan data. One of the most effective ways for the diagnosis of certain malignancies like lung tumours is Positron Emission Tomography (PET) imaging. So many diagnosis models have been implemented nowadays to diagnose various diseases. Early lung cancer identification is very important for predicting the severity level of lung cancer in cancer patients...
April 2024: Medical Engineering & Physics
https://read.qxmd.com/read/38617925/economic-assessment-of-ngs-testing-workflow-for-nsclc-in-a-healthcare-setting
#5
JOURNAL ARTICLE
Davide Seminati, Vincenzo L'Imperio, Gabriele Casati, Joranda Ceku, Daniela Pilla, Carla Rossana Scalia, Gianluca Gragnano, Francesco Pepe, Pasquale Pisapia, Luca Sala, Diego Luigi Cortinovis, Francesca Bono, Umberto Malapelle, Giancarlo Troncone, Silvia Novello, Fabio Pagni
BACKGROUND: The molecular diagnostic and therapeutic pathway of Non-Small Cell Lung Cancer (NSCLC) stands as a successful example of precision medicine. The scarcity of material and the increasing number of biomarkers to be tested have prompted the routine application of next-generation-sequencing (NGS) techniques. Despite its undeniable advantages, NGS involves high costs that may impede its broad adoption in laboratories. This study aims to assess the detailed costs linked to the integration of NGS diagnostics in NSCLC to comprehend their financial impact...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38615157/cell-mediated-nanoparticle-delivery-systems-towards-precision-nanomedicine
#6
REVIEW
Ruoyu Cheng, Shiqi Wang
Cell-mediated nanoparticle delivery systems (CMNDDs) utilize cells as carriers to deliver the drug-loaded nanoparticles. Unlike the traditional nanoparticle drug delivery approaches, CMNDDs take the advantages of cell characteristics, such as the homing capabilities of stem cells, inflammatory chemotaxis of neutrophils, prolonged blood circulation of red blood cells, and internalization of macrophages. Subsequently, CMNDDs can easily prolong the blood circulation, cross biological barriers, such as the blood-brain barrier and the bone marrow-blood barrier, and rapidly arrive at the diseased areas...
April 13, 2024: Drug Delivery and Translational Research
https://read.qxmd.com/read/38607736/exosomal-proteomics-unveiling-novel-insights-into-lung-cancer
#7
REVIEW
Guanhua Yi, Haixin Luo, Yalin Zheng, Wenjing Liu, Denian Wang, Yong Zhang
Although significant progress has been made in early lung cancer screening over the past decade, it remains one of the most prevalent and deadliest forms of cancer worldwide. Exosomal proteomics has emerged as a transformative field in lung cancer research, with the potential to redefine diagnostics, prognostic assessments, and therapeutic strategies through the lens of precision medicine. This review discusses recent advances in exosome-related proteomic and glycoproteomic technologies, highlighting their potential to revolutionise lung cancer treatment by addressing issues of heterogeneity, integrating multiomics data, and utilising advanced analytical methods...
April 11, 2024: Aging and Disease
https://read.qxmd.com/read/38605642/muscle-multi-view-and-multi-scale-attentional-feature-fusion-for-microrna-disease-associations-prediction
#8
JOURNAL ARTICLE
Boya Ji, Haitao Zou, Liwen Xu, Xiaolan Xie, Shaoliang Peng
MicroRNAs (miRNAs) synergize with various biomolecules in human cells resulting in diverse functions in regulating a wide range of biological processes. Predicting potential disease-associated miRNAs as valuable biomarkers contributes to the treatment of human diseases. However, few previous methods take a holistic perspective and only concentrate on isolated miRNA and disease objects, thereby ignoring that human cells are responsible for multiple relationships. In this work, we first constructed a multi-view graph based on the relationships between miRNAs and various biomolecules, and then utilized graph attention neural network to learn the graph topology features of miRNAs and diseases for each view...
March 27, 2024: Briefings in Bioinformatics
https://read.qxmd.com/read/38601551/the-effect-of-covid-19-on-cancer-incidences-in-the-u-s
#9
JOURNAL ARTICLE
Ramalingam Shanmugam, Larry Fulton, C Scott Kruse, Brad Beauvais, Jose Betancourt, Gerardo Pacheco, Rohit Pradhan, Keya Sen, Zo Ramamonjiarivelo, Arvind Sharma
Fundamental data analysis assists in the evaluation of critical questions to discern essential facts and elicit formerly invisible evidence. In this article, we provide clarity into a subtle phenomenon observed in cancer incidences throughout the time of the COVID-19 pandemic. We analyzed the cancer incidence data from the American Cancer Society [1]. We partitioned the data into three groups: the pre-COVID-19 years (2017, 2018), during the COVID-19 years (2019, 2020, 2021), and the post-COVID-19 years (2022, 2023)...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38600809/ad-aura-a-fresh-breeze-for-patients-with-resected-egfr-mutant-non-small-cell-lung-cancer
#10
JOURNAL ARTICLE
Nicole Conci, Andrea De Giglio, Francesca Sperandi, Barbara Melotti, Francesco Gelsomino
No abstract text is available yet for this article.
April 3, 2024: Chinese Clinical Oncology
https://read.qxmd.com/read/38595110/pathology-of-surgically-resected-lung-cancers-following-neoadjuvant-therapy
#11
JOURNAL ARTICLE
Sabina Berezowska, Mark Keyter, Hasna Bouchaab, Annikka Weissferdt
In around 30% of patients, non-small cell lung cancer is diagnosed at an advanced but resectable stage. Adding systemic therapy has shown clear benefit over surgery alone in locally advanced disease, and currently, chemo-immunotherapy in the adjuvant or neoadjuvant setting is the new standard for patients without targetable mutations. One major advantage of the neoadjuvant approach is the possibility of an immediate evaluation of the treatment effect, highlighting the role of pathology as an important contributor at the forefront of clinical decision-making and research...
April 9, 2024: Advances in Anatomic Pathology
https://read.qxmd.com/read/38584378/risk-factor-analysis-of-morbidity-and-90-day-mortality-of-curative-resection-in-patients-with-stage-iiia-n2-non-small-cell-lung-cancer-after-induction-concurrent-chemoradiation-therapy
#12
JOURNAL ARTICLE
Ga Hee Jeong, Junghee Lee, Yeong Jeong Jeon, Seong Yong Park, Hong Kwan Kim, Yong Soo Choi, Jhingook Kim, Young Mog Shim, Jong Ho Cho
BACKGROUND: Major pulmonary resection after neoadjuvant concurrent chemoradiation therapy (nCCRT) is associated with a substantial risk of postoperative complications. This study investigated postoperative complications and associated risk factors to facilitate the selection of suitable surgical candidates following nCCRT in stage IIIA-N2 non-small cell lung cancer (NSCLC). METHODS: We conducted a retrospective analysis of patients diagnosed with clinical stage IIIA-N2 NSCLC who underwent surgical resection following nCCRT between 1997 and 2013...
April 8, 2024: Journal of chest surgery
https://read.qxmd.com/read/38581958/study-protocol-for-two-stepped-wedge-interventional-trials-evaluating-the-effects-of-holistic-information-technology-based-patient-oriented-management-in-older-multimorbid-patients-with-cancer-the-geronte-trials
#13
JOURNAL ARTICLE
Marije E Hamaker, Hans Wildiers, Vittoria Ardito, Julie Arsandaux, Aurore Barthod-Malat, Paul Davies, Lien Degol, Lucia Ferrara, Celia Fourrier, Cindy Kenis, Marion Kret, Caroline Lalet, Simone Mathoulin Pelissier, Shane O'Hanlon, Siri Rostoft, Nelleke Seghers, Florence Saillour-Glénisson, Anthony Staines, Christine Schwimmer, Vincent Thevenet, Cedric Wallet, Pierre Soubeyran
INTRODUCTION: Current hospital-based care pathways are generally single-disease centred. As a result, coexisting morbidities are often suboptimally evaluated and managed, a deficiency becoming increasingly apparent among older patients who exhibit heterogeneity in health status, functional abilities, frailty, and other geriatric impairments. To address this issue, our study aims to assess a newly developed patient-centred care pathway for older patients with multimorbidity and cancer...
April 5, 2024: Journal of Geriatric Oncology
https://read.qxmd.com/read/38576413/the-causal-association-between-artificial-sweeteners-and-the-risk-of-cancer-a-mendelian-randomization-study
#14
JOURNAL ARTICLE
Haotian Pan, Chenchen Feng, Ziting Zhou, Jiamin Huang, Jiasi Deng, Yuanyuan Zhou, Yuxuan Wang, Xinru Mu, Qian Wang, Ke Wang, Zhigang Lu
Artificial sweeteners (ASs) have been widely added to food and beverages because of their properties of low calories and sweet taste. However, whether the consumption of ASs is causally associated with cancer risk is not clear. Here, we utilized the two-sample Mendelian randomization (MR) method to study the potential causal association. Genetic variants like single-nucleotide polymorphisms (SNPs) associated with exposure (AS consumption) were extracted from a genome-wide association study (GWAS) database including 64 949 Europeans and the influence of confounding was removed...
April 5, 2024: Food & Function
https://read.qxmd.com/read/38570169/immuno-chemoradiation-for-non-small-cell-lung-cancer-a-meta-analysis-of-factors-influencing-survival-benefit-in-combination-trials
#15
JOURNAL ARTICLE
Huei-Tyng Huang, Douglas H Brand, John D Fenwick, Maria A Hawkins
PURPOSE: Adding immune checkpoint blockade (ICB) to concurrent chemoradiotherapy (cCRT) has improved overall survival (OS) for inoperable locally advanced non-small cell lung cancer (LA-NSCLC). Trials of cCRT-ICB are heterogeneous for factors such as tumor stage and histology, PDL1 status and cCRT-ICB schedules. We therefore aimed to determine the ICB contribution to survival across studies and identify factors associated with survival gain. METHODS AND MATERIALS: Data were collated from cCRT-ICB clinical studies published 2018-2022 which treated 2196 NSCLC patients (99% stage III)...
April 1, 2024: International Journal of Radiation Oncology, Biology, Physics
https://read.qxmd.com/read/38568768/pathclip-detection-of-genes-and-gene-relations-from-biological-pathway-figures-through-image-text-contrastive-learning
#16
JOURNAL ARTICLE
Fei He, Kai Liu, Zhiyuan Yang, Yibo Chen, Richard D Hammer, Dong Xu, Mihail Popescu
In biomedical literature, biological pathways are commonly described through a combination of images and text. These pathways contain valuable information, including genes and their relationships, which provide insight into biological mechanisms and precision medicine. Curating pathway information across the literature enables the integration of this information to build a comprehensive knowledge base. While some studies have extracted pathway information from images and text independently, they often overlook the correspondence between the two modalities...
April 3, 2024: IEEE Journal of Biomedical and Health Informatics
https://read.qxmd.com/read/38558822/discovering-single-cannabidiol-or-synergistic-antitumor-effects-of-cannabidiol-and-cytokine-induced-killer-cells-on-non-small-cell-lung-cancer-cells
#17
JOURNAL ARTICLE
Yutao Li, Amit Sharma, Michèle J Hoffmann, Dirk Skowasch, Markus Essler, Hans Weiher, Ingo G H Schmidt-Wolf
INTRODUCTION: A multitude of findings from cell cultures and animal studies are available to support the anti-cancer properties of cannabidiol (CBD). Since CBD acts on multiple molecular targets, its clinical adaptation, especially in combination with cancer immunotherapy regimen remains a serious concern. METHODS: Considering this, we extensively studied the effect of CBD on the cytokine-induced killer (CIK) cell immunotherapy approach using multiple non-small cell lung cancer (NSCLC) cells harboring diverse genotypes...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38549499/assessing-egfr-mutated-nsclc-with-bone-metastasis-clinical-features-and-optimal-treatment-strategy
#18
JOURNAL ARTICLE
Wei-Chun Chen, Wen-Chien Cheng, Chieh-Lung Chen, Wei-Chih Liao, Chia-Hung Chen, Hung-Jen Chen, Chih-Yen Tu, Chi-Chen Lin, Te-Chun Hsia
BACKGROUND: This study aimed to examine the clinical characteristics of bone metastasis (BoM) in patients with non-small cell lung cancer (NSCLC) who have an epidermal growth factor receptor (EGFR) mutation and to identify the most effective treatment strategy using EGFR-tyrosine kinase inhibitors (TKIs). METHODS: The study included patients with stage IV EGFR-mutated NSCLC who were receiving first-line treatment with EGFR-TKIs between January 2014 and December 2020...
April 2024: Cancer Medicine
https://read.qxmd.com/read/38549290/-in-vitro-and-in-silico-antiproliferative-potential-of-isolated-flavonoids-constitutes-from-pistacia-integerrima
#19
JOURNAL ARTICLE
Abdur Rauf, Umer Rashid, Zuneera Akram, Momina Ghafoor, Naveed Muhammad, Najla Al Masoud, Taghrid S Alomar, Saima Naz, Marcello Iriti
Cancer is one of the most demanding domains for innovative, effective, safe, and affordable therapeutically active chemicals. The main aim of this study is to research new phytochemicals with anticancer activity. The current experiment identified and analyzed six compounds for anti-cancer potential supported by molecular simulation studies. The defatted methanolic extract underwent column chromatography, resulting in the isolation of six flavonoids. These include 3,5,7,4'-tetrahydroxy-flavanone ( 1 ), naringenin ( 2 ), 3,5,4'-trihydroxy-7-methoxy-flavanone ( 3 ), sakuranetin ( 4 ), spinacetin ( 5 ), and patuletin ( 6 )...
April 1, 2024: Zeitschrift Für Naturforschung. C, A Journal of Biosciences
https://read.qxmd.com/read/38548264/ribociclib-leverages-phosphodiesterase-4-inhibition-in-the-treatment-of-neutrophilic-inflammation-and-acute-respiratory-distress-syndrome
#20
JOURNAL ARTICLE
Po-Jen Chen, Shun-Hua Chen, Yu-Li Chen, Yi-Hsuan Wang, Cheng-Yu Lin, Chun-Hong Chen, Yung-Fong Tsai, Tsong-Long Hwang
INTRODUCTION: Overwhelming neutrophil activation and oxidative stress significantly contribute to acute respiratory distress syndrome (ARDS) pathogenesis. However, the potential of repurposing ribociclib, a cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor used clinically in cancer treatment, for treating neutrophilic ARDS remains uncertain. This study illustrated the ability and underlying mechanism of ribociclib for treating ARDS and neutrophilic inflammation. METHODS: Primary human neutrophils were used to determine the therapeutic effects of ribociclib on respiratory bursts, chemotactic responses, and inflammatory signaling...
March 27, 2024: Journal of Advanced Research
keyword
keyword
117397
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.